Earnings call transcript: Kura Oncology posts q3 2026 EPS beat, shares rise
AI Summary
Kura Oncology reported Q3 2026 earnings per share above expectations, and its shares rose. The article covers the company’s earnings-call transcript.
Related Articles
FG clears pension backlog, funds benefits until 2029
Punch Nigeria —
Has Nvidia flown too close to the sun? One analyst warns of major scrutiny ahead.
MarketWatch —
Avio 9M 2026 slides: 17% revenue growth, U.S. expansion accelerates
Investing.com —
Hyliion Q3 2026 slides: revenue soars on military work, outlook raised
Investing.com —
Popular EV, battery perks at risk as razor gang debates new cuts
The Sydney Morning Herald —
Oxford Nanopore at Canaccord forum: growth, margins and new uses
Investing.com —